Evaluating biomarkers to model cancer risk post cosmic ray exposure

Deepa M. Sridharan, Aroumougame Asaithamby, Steve R. Blattnig, Sylvain V. Costes, Paul W. Doetsch, William S. Dynan, Philip Hahnfeldt, Lynn Hlatky, Yared Kidane, Amy Kronenberg, Mamta D. Naidu, Leif E. Peterson, Ianik Plante, Artem L. Ponomarev, Janapriya Saha, Antoine M. Snijders, Kalayarasan Srinivasan, Jonathan Tang, Erica Werner, Janice M. Pluth

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Robust predictive models are essential to manage the risk of radiation-induced carcinogenesis. Chronic exposure to cosmic rays in the context of the complex deep space environment may place astronauts at high cancer risk. To estimate this risk, it is critical to understand how radiation-induced cellular stress impacts cell fate decisions and how this in turn alters the risk of carcinogenesis. Exposure to the heavy ion component of cosmic rays triggers a multitude of cellular changes, depending on the rate of exposure, the type of damage incurred and individual susceptibility. Heterogeneity in dose, dose rate, radiation quality, energy and particle flux contribute to the complexity of risk assessment. To unravel the impact of each of these factors, it is critical to identify sensitive biomarkers that can serve as inputs for robust modeling of individual risk of cancer or other long-term health consequences of exposure. Limitations in sensitivity of biomarkers to dose and dose rate, and the complexity of longitudinal monitoring, are some of the factors that increase uncertainties in the output from risk prediction models. Here, we critically evaluate candidate early and late biomarkers of radiation exposure and discuss their usefulness in predicting cell fate decisions. Some of the biomarkers we have reviewed include complex clustered DNA damage, persistent DNA repair foci, reactive oxygen species, chromosome aberrations and inflammation. Other biomarkers discussed, often assayed for at longer points post exposure, include mutations, chromosome aberrations, reactive oxygen species and telomere length changes. We discuss the relationship of biomarkers to different potential cell fates, including proliferation, apoptosis, senescence, and loss of stemness, which can propagate genomic instability and alter tissue composition and the underlying mRNA signatures that contribute to cell fate decisions. Our goal is to highlight factors that are important in choosing biomarkers and to evaluate the potential for biomarkers to inform models of post exposure cancer risk. Because cellular stress response pathways to space radiation and environmental carcinogens share common nodes, biomarker-driven risk models may be broadly applicable for estimating risks for other carcinogens.

Original languageEnglish (US)
Pages (from-to)19-47
Number of pages29
JournalLife Sciences in Space Research
Volume9
DOIs
StatePublished - 2016

Fingerprint

biomarkers
cosmic ray
biomarker
cosmic rays
Biomarkers
cancer
Neoplasms
Radiation
carcinogens
chromosome aberrations
dosage
carcinogen
cells
Chromosome Aberrations
chromosome
Reactive Oxygen Species
Carcinogenesis
radiation
deoxyribonucleic acid
telomeres

Keywords

  • Biomarkers
  • Cancer risk
  • HZE
  • Modeling
  • Space radiation

ASJC Scopus subject areas

  • Radiation
  • Ecology
  • Astronomy and Astrophysics
  • Health, Toxicology and Mutagenesis

Cite this

Sridharan, D. M., Asaithamby, A., Blattnig, S. R., Costes, S. V., Doetsch, P. W., Dynan, W. S., ... Pluth, J. M. (2016). Evaluating biomarkers to model cancer risk post cosmic ray exposure. Life Sciences in Space Research, 9, 19-47. https://doi.org/10.1016/j.lssr.2016.05.004

Evaluating biomarkers to model cancer risk post cosmic ray exposure. / Sridharan, Deepa M.; Asaithamby, Aroumougame; Blattnig, Steve R.; Costes, Sylvain V.; Doetsch, Paul W.; Dynan, William S.; Hahnfeldt, Philip; Hlatky, Lynn; Kidane, Yared; Kronenberg, Amy; Naidu, Mamta D.; Peterson, Leif E.; Plante, Ianik; Ponomarev, Artem L.; Saha, Janapriya; Snijders, Antoine M.; Srinivasan, Kalayarasan; Tang, Jonathan; Werner, Erica; Pluth, Janice M.

In: Life Sciences in Space Research, Vol. 9, 2016, p. 19-47.

Research output: Contribution to journalReview article

Sridharan, DM, Asaithamby, A, Blattnig, SR, Costes, SV, Doetsch, PW, Dynan, WS, Hahnfeldt, P, Hlatky, L, Kidane, Y, Kronenberg, A, Naidu, MD, Peterson, LE, Plante, I, Ponomarev, AL, Saha, J, Snijders, AM, Srinivasan, K, Tang, J, Werner, E & Pluth, JM 2016, 'Evaluating biomarkers to model cancer risk post cosmic ray exposure', Life Sciences in Space Research, vol. 9, pp. 19-47. https://doi.org/10.1016/j.lssr.2016.05.004
Sridharan, Deepa M. ; Asaithamby, Aroumougame ; Blattnig, Steve R. ; Costes, Sylvain V. ; Doetsch, Paul W. ; Dynan, William S. ; Hahnfeldt, Philip ; Hlatky, Lynn ; Kidane, Yared ; Kronenberg, Amy ; Naidu, Mamta D. ; Peterson, Leif E. ; Plante, Ianik ; Ponomarev, Artem L. ; Saha, Janapriya ; Snijders, Antoine M. ; Srinivasan, Kalayarasan ; Tang, Jonathan ; Werner, Erica ; Pluth, Janice M. / Evaluating biomarkers to model cancer risk post cosmic ray exposure. In: Life Sciences in Space Research. 2016 ; Vol. 9. pp. 19-47.
@article{8b4b0b07a10c40c897bc51056b81576a,
title = "Evaluating biomarkers to model cancer risk post cosmic ray exposure",
abstract = "Robust predictive models are essential to manage the risk of radiation-induced carcinogenesis. Chronic exposure to cosmic rays in the context of the complex deep space environment may place astronauts at high cancer risk. To estimate this risk, it is critical to understand how radiation-induced cellular stress impacts cell fate decisions and how this in turn alters the risk of carcinogenesis. Exposure to the heavy ion component of cosmic rays triggers a multitude of cellular changes, depending on the rate of exposure, the type of damage incurred and individual susceptibility. Heterogeneity in dose, dose rate, radiation quality, energy and particle flux contribute to the complexity of risk assessment. To unravel the impact of each of these factors, it is critical to identify sensitive biomarkers that can serve as inputs for robust modeling of individual risk of cancer or other long-term health consequences of exposure. Limitations in sensitivity of biomarkers to dose and dose rate, and the complexity of longitudinal monitoring, are some of the factors that increase uncertainties in the output from risk prediction models. Here, we critically evaluate candidate early and late biomarkers of radiation exposure and discuss their usefulness in predicting cell fate decisions. Some of the biomarkers we have reviewed include complex clustered DNA damage, persistent DNA repair foci, reactive oxygen species, chromosome aberrations and inflammation. Other biomarkers discussed, often assayed for at longer points post exposure, include mutations, chromosome aberrations, reactive oxygen species and telomere length changes. We discuss the relationship of biomarkers to different potential cell fates, including proliferation, apoptosis, senescence, and loss of stemness, which can propagate genomic instability and alter tissue composition and the underlying mRNA signatures that contribute to cell fate decisions. Our goal is to highlight factors that are important in choosing biomarkers and to evaluate the potential for biomarkers to inform models of post exposure cancer risk. Because cellular stress response pathways to space radiation and environmental carcinogens share common nodes, biomarker-driven risk models may be broadly applicable for estimating risks for other carcinogens.",
keywords = "Biomarkers, Cancer risk, HZE, Modeling, Space radiation",
author = "Sridharan, {Deepa M.} and Aroumougame Asaithamby and Blattnig, {Steve R.} and Costes, {Sylvain V.} and Doetsch, {Paul W.} and Dynan, {William S.} and Philip Hahnfeldt and Lynn Hlatky and Yared Kidane and Amy Kronenberg and Naidu, {Mamta D.} and Peterson, {Leif E.} and Ianik Plante and Ponomarev, {Artem L.} and Janapriya Saha and Snijders, {Antoine M.} and Kalayarasan Srinivasan and Jonathan Tang and Erica Werner and Pluth, {Janice M.}",
year = "2016",
doi = "10.1016/j.lssr.2016.05.004",
language = "English (US)",
volume = "9",
pages = "19--47",
journal = "Life Sciences in Space Research",
issn = "2214-5532",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Evaluating biomarkers to model cancer risk post cosmic ray exposure

AU - Sridharan, Deepa M.

AU - Asaithamby, Aroumougame

AU - Blattnig, Steve R.

AU - Costes, Sylvain V.

AU - Doetsch, Paul W.

AU - Dynan, William S.

AU - Hahnfeldt, Philip

AU - Hlatky, Lynn

AU - Kidane, Yared

AU - Kronenberg, Amy

AU - Naidu, Mamta D.

AU - Peterson, Leif E.

AU - Plante, Ianik

AU - Ponomarev, Artem L.

AU - Saha, Janapriya

AU - Snijders, Antoine M.

AU - Srinivasan, Kalayarasan

AU - Tang, Jonathan

AU - Werner, Erica

AU - Pluth, Janice M.

PY - 2016

Y1 - 2016

N2 - Robust predictive models are essential to manage the risk of radiation-induced carcinogenesis. Chronic exposure to cosmic rays in the context of the complex deep space environment may place astronauts at high cancer risk. To estimate this risk, it is critical to understand how radiation-induced cellular stress impacts cell fate decisions and how this in turn alters the risk of carcinogenesis. Exposure to the heavy ion component of cosmic rays triggers a multitude of cellular changes, depending on the rate of exposure, the type of damage incurred and individual susceptibility. Heterogeneity in dose, dose rate, radiation quality, energy and particle flux contribute to the complexity of risk assessment. To unravel the impact of each of these factors, it is critical to identify sensitive biomarkers that can serve as inputs for robust modeling of individual risk of cancer or other long-term health consequences of exposure. Limitations in sensitivity of biomarkers to dose and dose rate, and the complexity of longitudinal monitoring, are some of the factors that increase uncertainties in the output from risk prediction models. Here, we critically evaluate candidate early and late biomarkers of radiation exposure and discuss their usefulness in predicting cell fate decisions. Some of the biomarkers we have reviewed include complex clustered DNA damage, persistent DNA repair foci, reactive oxygen species, chromosome aberrations and inflammation. Other biomarkers discussed, often assayed for at longer points post exposure, include mutations, chromosome aberrations, reactive oxygen species and telomere length changes. We discuss the relationship of biomarkers to different potential cell fates, including proliferation, apoptosis, senescence, and loss of stemness, which can propagate genomic instability and alter tissue composition and the underlying mRNA signatures that contribute to cell fate decisions. Our goal is to highlight factors that are important in choosing biomarkers and to evaluate the potential for biomarkers to inform models of post exposure cancer risk. Because cellular stress response pathways to space radiation and environmental carcinogens share common nodes, biomarker-driven risk models may be broadly applicable for estimating risks for other carcinogens.

AB - Robust predictive models are essential to manage the risk of radiation-induced carcinogenesis. Chronic exposure to cosmic rays in the context of the complex deep space environment may place astronauts at high cancer risk. To estimate this risk, it is critical to understand how radiation-induced cellular stress impacts cell fate decisions and how this in turn alters the risk of carcinogenesis. Exposure to the heavy ion component of cosmic rays triggers a multitude of cellular changes, depending on the rate of exposure, the type of damage incurred and individual susceptibility. Heterogeneity in dose, dose rate, radiation quality, energy and particle flux contribute to the complexity of risk assessment. To unravel the impact of each of these factors, it is critical to identify sensitive biomarkers that can serve as inputs for robust modeling of individual risk of cancer or other long-term health consequences of exposure. Limitations in sensitivity of biomarkers to dose and dose rate, and the complexity of longitudinal monitoring, are some of the factors that increase uncertainties in the output from risk prediction models. Here, we critically evaluate candidate early and late biomarkers of radiation exposure and discuss their usefulness in predicting cell fate decisions. Some of the biomarkers we have reviewed include complex clustered DNA damage, persistent DNA repair foci, reactive oxygen species, chromosome aberrations and inflammation. Other biomarkers discussed, often assayed for at longer points post exposure, include mutations, chromosome aberrations, reactive oxygen species and telomere length changes. We discuss the relationship of biomarkers to different potential cell fates, including proliferation, apoptosis, senescence, and loss of stemness, which can propagate genomic instability and alter tissue composition and the underlying mRNA signatures that contribute to cell fate decisions. Our goal is to highlight factors that are important in choosing biomarkers and to evaluate the potential for biomarkers to inform models of post exposure cancer risk. Because cellular stress response pathways to space radiation and environmental carcinogens share common nodes, biomarker-driven risk models may be broadly applicable for estimating risks for other carcinogens.

KW - Biomarkers

KW - Cancer risk

KW - HZE

KW - Modeling

KW - Space radiation

UR - http://www.scopus.com/inward/record.url?scp=84979642676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979642676&partnerID=8YFLogxK

U2 - 10.1016/j.lssr.2016.05.004

DO - 10.1016/j.lssr.2016.05.004

M3 - Review article

C2 - 27345199

AN - SCOPUS:84979642676

VL - 9

SP - 19

EP - 47

JO - Life Sciences in Space Research

JF - Life Sciences in Space Research

SN - 2214-5532

ER -